You are here:HomeLive TVVideosExpect $125-150 Mn From Oral Contraceptives Business: Lupin

Expect $125-150 mn from oral contraceptives business: Lupin

loading..

Lupin has received approval to launch the generic version of oral contraceptive Yasmin in the US. Ramesh Swaminathan, president of finance and planning, Lupin, explains this is a crucial product for the pharma company and could help them garner $125-150 million dollars over time. He adds that Lupin has a strong pipeline of launches for the year ahead as well.


Social Sharing

Advertisement

Advertisement

Portfolio
 

Advertisement

Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2014. All rights reserved.